|
🦁
|
Epidemiology of coronary heart disease and acute coronary syndrome.
F. Sanchis-Gomar,
C. Pérez-Quilis,
R. Leischik,
A. Lucia
|
10 |
2016 |
10
🦁
|
|
🐬
|
Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge
G. Lippi,
F. Sanchis-Gomar,
G. Cervellin
|
9 |
2020 |
9
🐬
|
|
🐬
|
Red blood cell distribution width: A simple parameter with multiple clinical applications
G. Salvagno,
F. Sanchis-Gomar,
A. Picanza,
G. Lippi
|
9 |
2015 |
9
🐬
|
|
🐢
|
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis
G. Lippi,
C. Lavie,
F. Sanchis-Gomar
|
9 |
2020 |
9
🐢
|
|
🐬
|
Exercise acts as a drug; the pharmacological benefits of exercise
J. Viña,
F. Sanchis-Gomar,
V. Martínez-Bello,
M. Gómez-Cabrera
|
8 |
2012 |
8
🐬
|
|
🐢
|
Global epidemiology and future trends of heart failure
G. Lippi,
F. Sanchis-Gomar
|
8 |
2020 |
8
🐢
|
|
🐜
|
Exercise attenuates the major hallmarks of aging.
9 auth.
N. Garatachea,
H. Pareja-Galeano,
F. Sanchis-Gomar,
A. Santos-Lozano,
C. Fiuza-Luces,
M. Morán,
...
E. Emanuele,
M. Joyner,
A. Lucia
|
8 |
2015 |
8
🐜
|
|
🐬
|
Metabolic Impacts of Confinement during the COVID-19 Pandemic Due to Modified Diet and Physical Activity Habits
María Martínez-Ferrán,
Fernando de la Guía-Galipienso,
F. Sanchis-Gomar,
H. Pareja-Galeano
|
8 |
2020 |
8
🐬
|
|
🐢
|
Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19)
G. Lippi,
B. Henry,
C. Bovo,
F. Sanchis-Gomar
|
8 |
2020 |
8
🐢
|
|
🐢
|
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19)
G. Lippi,
B. Henry,
F. Sanchis-Gomar
|
8 |
2020 |
8
🐢
|
|
🦁
|
Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide
F. Sanchis-Gomar,
C. Lavie,
M. Mehra,
B. Henry,
G. Lippi
|
8 |
2020 |
8
🦁
|
|
🐬
|
Concise update on colorectal cancer epidemiology.
C. Mattiuzzi,
F. Sanchis-Gomar,
G. Lippi
|
7 |
2019 |
7
🐬
|
